Similar articles

• The influence of compression and formulation on the hardness, disintegration, dissolution, absorption and excretion of sulphadimidine tablets.

  van Oudtshoorn MC, Potgieter FJ, de Blaey CJ, Polderman J. van Oudtshoorn MC, et al. J Pharm Pharmacol. 1971 Aug;23(8):583-6. doi: 10.1111/j.2042-7158.1971.tb08720.x. J Pharm Pharmacol. 1971. PMID: 4397740 No abstract available.
• Effect of exercise on plasma levels and urinary excretion of sulphadimidine and procainamide.

  Ylitalo P, Hinkka H. Ylitalo P, et al. Int J Clin Pharmacol Ther Toxicol. 1985 Oct;23(10):548-53. Int J Clin Pharmacol Ther Toxicol. 1985. PMID: 4066079
• Urinary excretion of sulphadimidine after oral administration of four proprietary brands.

  Mattie H, van der Meer J, Noach EL. Mattie H, et al. Folia Med Neerl. 1972;15(3):155-60. Folia Med Neerl. 1972. PMID: 5041598 No abstract available.
• [Technological processes and the influence of adjuvants on the dissolution rate and absorption of some ingredients from tablets. V. Release and absorption capacity of sulfadimidine].

  Tencova A, Kiszeleva G, Selmeczi B, Kedvessy G, Nagy G. Tencova A, et al. Acta Pharm Hung. 1984 Nov;54(6):245-8. Acta Pharm Hung. 1984. PMID: 6516863 Hungarian. No abstract available.
• Effect of concomitant isoniazid administration on determination of acetylator phenotype by sulphadimidine.

  Zysset T, Peretti E. Zysset T, et al. Eur J Clin Pharmacol. 1986;30(4):463-6. doi: 10.1007/BF00607961. Eur J Clin Pharmacol. 1986. PMID: 3743623